In Bloomberg Law, Abigail Gregor and Georgina Jones Suzuki Examine Drafting Life Sciences Collaborations & Licenses in a Downturn

In The News
November 17, 2022

While public financing for private biotechnology companies has been severely affected by the economic downturn, deal dynamics for collaborations and licensing transactions have also been impacted, providing insight into key considerations for the negotiation of collaboration and licensing agreements in a volatile environment.

In a Bloomberg Law article, life sciences partner Abigail Gregor and intellectual property transactions associate Georgina Jones Suzuki analyze deal process and transaction structures, economics, research and development programs, and insolvency matters with the aim to provide attorneys and business development professionals in the life sciences industry with the tools to identify creative solutions and close deals.